ASND icon

Ascendis Pharma

132 hedge funds and large institutions have $5.49B invested in Ascendis Pharma in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more capital invested

Capital invested by funds: $ → $

4% less funds holding

Funds holding: 138132 (-6)

16% less funds holding in top 10

Funds holding in top 10: 1916 (-3)

22% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 23

Holders
132
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
16
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$109M
Puts
$29.5M
Net Calls
Net Calls Change

Top Sellers

1 -$73.7M
2 -$42.5M
3 -$33.1M
4
Millennium Management
Millennium Management
New York
-$30.1M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$27.8M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$827M
2
$540M
3
$476M
4
$443M
5
$390M
6
$237M
7
$227M
8
$196M
9
$183M
10
$177M
11
$129M
12
$127M
13
$117M
14
$112M
15
$101M
16
$101M
17
$88.5M
18
$74.8M
19
$58.1M
20
$58M
21
$57.6M
22
$54.5M
23
$52.3M
24
$46.1M
25
$44.3M